Updated: January 26, 2026
Prucalopride Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
What are the most common prucalopride (Motegrity) side effects, and when should you be concerned? Learn what to expect, what usually passes, and when to call your doctor.
Starting a new medication always comes with questions about what you might feel. Prucalopride (Motegrity) is generally well-tolerated, but like all medications, it can cause side effects — some expected and temporary, others requiring medical attention. Here's a complete, honest breakdown of what to expect.
The Most Common Side Effects (What Most People Experience at First)
In clinical trials of over 2,400 patients, the most commonly reported side effects of prucalopride were:
- Headache: One of the most frequently reported side effects. Usually mild to moderate and most common in the first few days of treatment.
- Nausea: Reported in up to 19.6% of patients. Most nausea occurs at the start of therapy and typically resolves within a few days of continued treatment.
- Abdominal pain: Reported in up to 16% of patients. Usually described as cramping or discomfort; typically improves as your body adjusts.
- Diarrhea: Reported in up to 13% of patients. This is largely a direct extension of the drug's intended effect on bowel motility.
- Abdominal distension, vomiting, flatulence: Reported in ≥2% of patients. Often transient.
- Dizziness and fatigue: Also commonly reported, especially in the early weeks of treatment.
The good news: according to clinical trial data, the majority of these GI side effects occur predominantly at the start of therapy and usually disappear within a few days of continued treatment. Many patients who push through the first week find that side effects diminish significantly.
Tips for Managing Common Side Effects
- Nausea: Take prucalopride with a small snack if nausea occurs (it can be taken with or without food). Stay hydrated.
- Headache: OTC pain relievers (acetaminophen, ibuprofen) are generally safe to use unless your doctor advises otherwise. Most headaches resolve without any treatment within the first 1–2 weeks.
- Diarrhea: Ensure adequate fluid intake. If diarrhea is severe or persistent, contact your doctor — they may adjust your dose.
Serious Side Effect: Suicidal Ideation and Behavior
Prucalopride's prescribing information includes a warning for suicidal ideation and behavior based on reports from clinical trials and post-marketing data. While a direct causal relationship has not been established, this is considered a serious potential risk.
Post-marketing reports have included: suicidal thoughts, suicide attempts, self-injurious ideation, depression, anxiety, insomnia, nightmares, and visual hallucinations.
What to do: Stop taking prucalopride immediately and contact your healthcare provider if you experience any unusual changes in mood, persistent worsening of depression, or thoughts of self-harm. If you are in a mental health emergency, call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.
Serious Side Effect: Severe Allergic Reaction
Though rare, prucalopride can cause hypersensitivity reactions including:
- Difficulty breathing (dyspnea)
- Rash, itching (pruritus), or hives (urticaria)
- Swelling of the face, lips, tongue, or throat (facial edema)
What to do: Stop the medication and seek emergency medical care immediately. This is a contraindication to further prucalopride use.
Does Prucalopride Have a Black Box Warning?
No. Prucalopride does not have a boxed (black box) warning — the strongest type of FDA warning. The suicidal ideation warning is listed under "Warnings and Precautions" in the prescribing information, which is a serious but lower-level designation than a boxed warning.
Cardiovascular Safety
Early concerns about 5-HT4 agonists and cardiovascular risk (based on other drugs in the class, notably cisapride) have not materialized for prucalopride. Post-marketing observational studies using European healthcare databases found no increased risk of major adverse cardiovascular events (MACE) in prucalopride users compared to patients taking polyethylene glycol (PEG) laxative. Clinical QT interval studies also showed no significant differences from placebo.
When to Call Your Doctor
Contact your prescriber if you experience:
- Nausea or diarrhea that does not improve after 1–2 weeks of treatment
- Severe abdominal pain or cramping
- Signs of an allergic reaction (rash, swelling, difficulty breathing)
- Any changes in mood, new or worsening depression, or suicidal thoughts
- Signs of severe dehydration from diarrhea or vomiting (extreme thirst, dark urine, dizziness)
For more information on how prucalopride interacts with other medications you may be taking, see: Prucalopride Drug Interactions: What to Avoid and What to Tell Your Doctor
Frequently Asked Questions
Most common side effects — nausea, headache, abdominal pain, and diarrhea — occur predominantly at the start of therapy and usually resolve within a few days of continued treatment. Clinical trial data showed that GI side effects were most common in the first 24 hours after the initial dose.
Prucalopride's prescribing information includes a warning that suicidal ideation and behavior have been reported in patients taking the drug. A direct causal relationship has not been established. Patients should report any changes in mood, worsening depression, or suicidal thoughts to their doctor immediately and discontinue the medication. Call 988 if you are in a mental health crisis.
Prucalopride is primarily eliminated by the kidneys. It is not typically harmful to kidneys in patients with normal or mildly impaired kidney function. However, patients with severe renal impairment (CrCl < 30 mL/min) require a reduced 1 mg dose, and prucalopride is contraindicated in patients with end-stage renal disease (ESRD) requiring dialysis.
Diarrhea is one of the most common side effects of prucalopride, reported in up to 13% of patients in clinical trials. It is usually mild to moderate and often improves after the first few days. If diarrhea is severe, persistent, or causing dehydration, contact your doctor — they may adjust your dose.
Current evidence does not show prucalopride causes heart problems. Unlike earlier 5-HT4 agonists (cisapride, tegaserod), prucalopride has high selectivity for 5-HT4 receptors and does not affect cardiac hERG channels. Post-market cardiovascular safety studies found no increased MACE risk compared to polyethylene glycol laxative.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Prucalopride also looked for:
More about Prucalopride
33,433 have already found their meds with Medfinder.
Start your search today.





